QUALITY STUDY OF INTRAVENOUS MIXTURES AFTER THE IMPLEMENTATION OF DOUBLE CHECK
PP-020
CONTROVERSIES IN THE CONDUCTING OF DRUG PATCH TESTING
PP-019
CENTRALISED IV COMPOUNDING: A PRE-FEASIBILITY STUDY IN CLINICAL PRACTICE
PP-018
DRUG SAVINGS REALISED BY USE OF A RIGHT CLOSED SYSTEM TRANSFER DEVICE IN THE PREPARATION OF ANTINEOPLASTIC DRUGS
PP-017
THE PHYSICAL STABILITY OF INJECTABLE DRUGS MUST BE PROVED TO ENSURE PATIENT SAFETY
PP-016
LONG TERM STABILITY OF A GENERIC PRODUCT OF PIPERACILLINE/TAZOBACTAM IN GLUCOSE 5% INFUSION POLYOLEFIN BAGS AT 5°C ± 3°C AFTER MICROWAVE FREEZE–THAW TREATMENT
PRACTICAL APPLICATION OF RISK ASSESSMENT IN PHARMACY PREPARATIONS BASED ON EUROPEAN RESOLUTION CM/RESAP(2011)1
PP-012
TRACEABILITY AND SAFETY IN THE PREPARATION OF CYTOTOXIC DRUGS
PP-011
IMPACT OF WORKLOAD ON PREPARATIONS QUALITY IN CHEMOTHERAPY: A PILOT SIMULATION STUDY
PP-010
IMPLEMENTING A STANDARD OPERATING PROCEDURE OF THIOGUANINE 40 MG/ML COMPOUNDED MEDICINE
PP-009
IDENTIFYING AND LOCALISING MOLECULAR POLARITIES AS A BASIC PROCESS TO PREDICT COMPATIBLE AQUEOUS DRUG MIXTURES
PP-008
QUALITY RISK MANAGEMENT: MICROBIOLOGIC PROCESS VALIDATION FOR SEMISOLID FORMULATIONS USING THE FAILURE MODE EFFECT ANALYSIS
PP-007
EVALUATION OF AMYLASE-RESISTANT GELLAN GUM (E418) AS A RHEOLOGY AND TEXTURE MODIFIER FOR ORAL PREPARATIONS
PP-006
A NOVEL HALOGENATED ANAESTHETIC SOLUTION: PHYSICAL AND CHEMICAL STABILITY STUDY
PP-005
STABILITY OF HOSPITAL PHARMACY PREPARED HEPARIN SOLUTIONS
